Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute necrotizing encephalitis
adverse drug reaction
altered states of consciousness
amphiphysin antibodies
analgesic
antiviral agents
ataxia, cerebellar
atypical
autoantibodies
autoimmune disease
autonomic neuropathy
axonal degeneration
B cell lymphocyte depletion
B cell lymphocytes
bacterial infection
bacterial infection, CNS
behavioral disorder
Borrelia burgdorferi infection
brain biopsy
brain scan
calcification, intracranial
campylobacter infection
carcinoma
carcinoma of lung
cataracts, congenital
central nervous system, infection of
cerebellar degeneration
cerebrospinal fluid
cerebrospinal fluid, culture of
cerebrospinal fluid, cytology
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, xanthochromia of
children
chlamydia infection
chorioretinitis
chronic fatigue syndrome
collapsin response mediator protein 5 IgG
concentration, impaired
confusion
contactin associated protein like 2 antibodies
controversies in neurology
cost
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
demyelinating disease
depression
depression, psychotic
dermatomyositis
diabetes mellitus
diarrhea
disability rating scale, neurological
disability, neurological
down-beat nystagmus
drug induced neurologic disorders
electrical injury of nervous system
electroencephalogram
electroencephalogram, abnormalities of
electron microscopy
ELISA
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalomyelitis
epidemiology of neurology
episodic disorders
Epstein-Barr virus
ergotamine
etanercept
facial nerve palsy
familial
fatigue
fellowship training
fever
Fisher's syndrome
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
gastroenteritis
genetic neurologic disorders
glioblastoma multiforme(astrocytoma Gr.III)
glutamic acid decarboxylase, antibody
gram negative rod
gray matter
Guillain Barre syndrome
Guillain Barre syndrome, axonal form
Guillain Barre syndrome, complications
Guillain Barre syndrome, differential diagnosis of
Guillain Barre syndrome, etiology of
Guillain Barre syndrome, prognosis of
head injury
headache
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes virus infection
herpes zoster
herpes, genital
HLA
human herpesvirus 6
human T-lymphotropic virus type I(HTLV-I)
hydrocephalus
hypoglycorrhachia
imbalance
immunofluorescence
immunofluorescent exam of CSF cells
immunologic disease
immunology and the nervous system
immunosuppression
immunotherapy
inclusion bodies, intranuclear
inclusion body myositis
infection
infectious mononucleosis
infliximab
interferon
interferon beta 1-a
interferon beta 1-b
interferon inducer
intestinal biopsy
intracranial pressure, increased
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
JC virus
lateropulsion
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
limbic system
Lyme disease
lymphadenopathy
malformation, CNS, congenital
malignancy screen
malignancy, occult
memory, impairment of
meningitis
meningitis, aseptic
mental status, abnormal
microcephaly
micropthalmia
migraine
migraine, pathogenesis
migraine, prophylaxis
migraine, treatment of
monoamines
monoamines, brain
monoclonal antibodies
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength, high
MRI, lesion burden
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, spinal cord
MRS
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, clinical patterns
multiple sclerosis, conjugal
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, epidemiology of
multiple sclerosis, etiology of
multiple sclerosis, familial
multiple sclerosis, lesion location
multiple sclerosis, linoleic acid in
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, plaque
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle pain
myasthenia gravis
myasthenia gravis, etiology of
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelitis
myositis
N-acetyl-L-aspartic acid
neoplasm, primary intracerebral
nerve conduction studies
neuroimmunology
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic signs
neurologic symptoms
neurologic testing
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuroophthalmology
neuropathology
neuropathology, brain
neuropathy, paraneoplastic
neuroprotective agents
NMDA antagonists
nonsteroidal anti-inflammatory drug
nystagmus
onconeural antibodies
opsoclonus-myoclonus syndrome
optic atrophy
papovavirus
parainfluenza virus
paraneoplastic cerebellar degeneration
peripheral nerve, lesion of
personality change
plasmapheresis
pleocytosis of cerebrospinal fluid
polyinosinic cytidic acid(poly IC)
polymerase chain reaction
polymyositis
polyneuropathy, chronic inflammatory demyelinating
post infectious polyneuropathy
postviral fatigue syndrome
precipitating factors
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
Red flags
remote effect of cancer on the nervous system
respiratory tract infection
retinopathy
retrovirus
reversible neurologic disorder
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
rituximab
rubella virus
rubeola virus
safety
screening
seizure
seizure, psychomotor-temporal lobe
serologic testing
seronegative
serotonin agonist
sinusitis
spinal cord, lesion of
spirochete infection
steroid therapy, CNS treatment and complications with
stool culture
stress, emotional
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subtemporal decompression
sun exposure
talk
temporal lobe, lesion
temporal lobe, lesion, bilateral
tetanus toxoid
transient neurologic deficit
transplacental virus infections
trauma
treatment of neurologic disorder
trigeminal neuralgia
trigeminovascular system
triptans
tumor necrosis factor
tumor necrosis factor inhibitor
twins
ultraviolet light
vaccination, neurologic complications with
vaccine
viral infection
viral infection, CNS
visual loss
vitamin D
wheelchair
white matter disease
workup
Showing articles 450 to 500 of 4257 << Previous Next >>

Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Picturing Multiple Sclerosis: Conventional and Diffusion Tensor Imaging
Semin Neurol 28:453-466, Fox,R.J., 2008

Intracranial Hemorrhage in Children
Arch Neurol 65:1629-1633, Lo,W.D.,et al, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

4-Aminopyridine Toxicity with Unintentional Overdose in Four Patients with Multiple Sclerosis
Neurol 71:1833-1834, Burton,J.M.,et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Combining Beta Interferon and Atorvastatin May Increase Disease Activity in Multiple Sclerosis
Neurol 71:1390-1395,1386, Birnbaum,G.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

NMO Antibody-Positive Recurrent Optic Neuritis Without Clear Evidence of Transverse Myelitis
Arch Ophthalmol 126:566-570, Dinkin,M.J.,et al, 2008

Gray Matter Atrophy in Multiple Sclerosis: A Longitudinal Study
Ann Neurol 64:255-265,230, Fisher,E.,et al, 2008

Curable Cause of Paraplegia: Spinal Dural Arteriovenous Fistulae
Stroke 39:2756-2759, Aghakhani,N.,et al, 2008

Neurologic Manifestations of Localized Scleroderma: A Case Report and Literature Review
Neurol 71:1538-1545, Kister,I.,et al, 2008

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study
Lancet 372:1463-1472, Kappos,L.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

NMO-IgG Predicts the Outcome of Recurrent Optic Neuritis
Neurol 70:2197-2200, Matiello,M.,et al, 2008

Mlutiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-Up
Arch Neurol 65:727-732, The Optic Neuritis Study Group, 2008

Hyperdense Internal Carotid Artery Sign: A CT Sign of Acute Ischemia
Stroke 39:2011-2016, Ozdemir,O.,et al, 2008

Effect of Laquinimod on MRI-Monitored Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIb Study
Lancet 371:2085-2092,2059, Comi,G.,etc., 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Four New Cases of Therapy-Related Acute Promyelocytic Leukemia After Mitoxantrone
Neurol 71:457-458, Bosca,I.,et al., 2008

Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage: The FUNC Score
Stroke 39:2304-2309, Rost,N.S.,et al., 2008

Multiple Sclerosis and Cannabis: A Cognitive and Psychiatric Study
Neurol 71:164-169, Ghaffar,O. &Feinstein,A., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Finding NMO: Neuromyelitis Optica in Chidlren
Neurol 70:334-335, Levy,M.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008

Unexpected Multiple Sclerosis: Follow-Up of 30 Patients With Magnetic Resonance Imaging and Clinical Conversion Profile
JNNP 79:195-198,112, Lebrun,C.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

Non-Communicating Syringomyelia: A Feature of Spinal Cord Involvement in Multiple Sclerosis
Brain 131:1776-1782, Weier,K.,et al, 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

Sporadic Adult-Onset Leukoencephalopathy with Neuroaxonal Spheroids Mimicking Cerebral MS
Neurol 70:1128-1133, Keegan,B.M.,et al, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Brain Magnetic Resonance Imaging Abnormalities in Neuromyelitis Optica
Acta Neurol Scand 118:218-225, Li, Y.,et al, 2008

Asymmetric Cerebellar Ataxia and Limbic Encephalitis as a Presenting Feature of Primary Sjogrens Syndrome
J Neurol 254:1609-1611, Collison,K. and Rees,J., 2007

Differential Diagnosis of Bilateral Thalamic Lesions
Clin Neuroradiol 17:3-22, Linn,J.,et al, 2007

Course and Outcome of Acute Limbic Encephalitis With Negative Voltage-Gated Potassium Channel Antibodies
JNNP 78:391-394, Samarasekera,S.R., et al, 2007

CSF Analysis in Patients With Sporadic CJD and Other Transmissible Spongiform Encephalopathies
Eur J Neurol 14:121-124, Green,A.,et al, 2007

Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007

Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
AJNR 28:1639-1644, Ge,Y.,et al, 2007



Showing articles 450 to 500 of 4257 << Previous Next >>